1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
RNAi Technologies and Global Markets

RNAi Technologies and Global Markets

  • January 2016
  • 176 pages
  • ID: 1715880

Summary

Table of Contents

This BCC Research report summarizes the global RNAi technologies market by category and by region. The RNAi market is analyzed based on RNAi research tools and reagents as well as on RNAi diagnostics. The report includes sales forecasts from 2015 to 2020.

Use this report to:

Analyze the market prospects of ribonucleic acid interference (RNAi) technology
Evaluate the product usage, research and development, collaborations, market trends
and future applications, prospects, challenges, etc. in the RNAi market Assess the progress of new RNAi techniques in the areas of research tools and products, therapeutics, diagnostics and agricultural segments
Gain information on the regulatory aspects, drivers and other factors of RNAi market

Highlights

The global market for RNA interference technologies is expected to grow from $262.1 million in 2015 to $392.6 million in 2020, registering a compound annual growth rate (CAGR) of 8.4%.
The RNAi research tools and reagents market is projected to reach $391.0 million in 2020 from $261.1 million in 2015, increasing at a CAGR of 8.4%.
The RNAi diagnostics market reached $1.0 million in 2015 and should reach $1.6 million by 2020 growing at a CAGR of 9.9%.

STUDY OBJECTIVES

BCC Research conducted this report to analyze the market prospects of ribonucleic acid interference (RNAi) technology. The report assesses the progress of new RNAi techniques in the areas of research tools and products, therapeutics, diagnostics andagricultural segments. Further, the report evaluates the product usage, research and development, collaborations, market trends and future applications, prospects, challenges, etc. in the RNAi market.

Global RNAi technology is in its nascent state. However, the market holds significant opportunities due to the promising application of RNAi therapeutics in often-fatal diseases like cancer, heart ailments, autoimmune diseases, neurodegenerative disease and others. The RNAi research tools and reagents market is growing well due to its major applications in RNAi therapeutics, diagnostics and agricultural areas. Secondly, various RNAi therapeutics candidates are showing success in advanced stages of their clinical investigations. Further, the availability of RNAi diagnostics tests offer great promises of successful application of RNAi therapeutics and diagnostics in medical settings.

The market projections are based on the commercialized research products and tools and trends in their applications, product development, applications in diagnostics, and investments for RNAi therapeutics, agricultural products and other areas. The report provides present market analysis as well as a projection for the next five years (until 2020). The report includes market analysis, market leaders, manufacturers and market shares, profiles of leading companies, current situations, new developments, patent analysis, regulatory aspects, drivers and other factors of RNAi market.

REASONS FOR DOING THIS STUDY

The RNAi market is burgeoning and is one of the most watched markets in the pharmaceuticals industry. The reason for this status is the encouraging application of RNAi mechanisms in therapeutics through gene silencing. There is no approved therapy so far; however, various candidates have shown successful results in their
clinical investigations. The report reflects the details of those candidates along with prospective applications of RNAi in diagnostics and agriculture. This market will grow through 2020 with the successful utilization of techniques in both therapeutics and agriculture.



Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
3D Cell Culture Market by Product, Microfluidics, Magnetic Levitation), Application, End User - Global Forecast to 2022

3D Cell Culture Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • November 2017
  • by MarketsandMarkets

“Global 3D cell culture market projected to grow at a CAGR of 20.3%”The 3D cell culture market is expected to reach USD 1,702.3 million by 2022 from USD 682.8 million in 2017, at a CAGR of 20.3%. The ...

Stem Cell Therapy for Diabetes and Related Conditions - A Pipeline Analysis Report

Stem Cell Therapy for Diabetes and Related Conditions - A Pipeline Analysis Report

  • $ 3500
  • Industry report
  • October 2017
  • by Infiniti Research Limited

Stem cell therapy for diabetes and related conditions: An insightThe stem cell therapy for diabetes and related conditions pipeline analysis report includes ongoing clinical and non-clinical trends in ...

Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H2, 2017

Clinical Research in Idiopathic Pulmonary Fibrosis in H2, 2017

  • $ 2500
  • Industry report
  • October 2017
  • by GlobalData

Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H2, 2017SummaryGlobalData’s clinical trial report, “Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H2, 2017" provides an overview ...


ref:plp2016

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.